IONIS PHARMACEUTICALS INC (IONS) Stock Analyst Ratings
NASDAQ:IONS - Nasdaq - US4622221004 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to IONS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 59.07. This target is 76.53% above the current price.
IONS was analyzed by 32 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IONS.
In the previous month the buy percentage consensus was at a similar level.
IONS was analyzed by 32 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-01 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-30 | Needham | Maintains | Buy -> Buy |
| 2025-04-15 | Needham | Reiterate | Buy -> Buy |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-04-07 | HC Wainwright & Co. | Initiate | Buy |
| 2025-04-03 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-31 | Redburn Atlantic | Initiate | Neutral |
| 2025-03-24 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-03-11 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-02-20 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-02-20 | Needham | Reiterate | Buy -> Buy |
| 2025-02-20 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-02-20 | Citigroup | Maintains | Buy -> Buy |
| 2025-01-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-12-20 | Needham | Maintains | Buy -> Buy |
| 2024-11-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-07 | Needham | Reiterate | Buy -> Buy |
| 2024-11-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-09 | Guggenheim | Maintains | Buy -> Buy |
| 2024-09-26 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-26 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-08-02 | Guggenheim | Maintains | Buy -> Buy |
| 2024-08-02 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2024-08-02 | Needham | Reiterate | Buy -> Buy |
| 2024-08-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-02 | Goldman Sachs | Maintains | Sell -> Sell |
| 2024-07-24 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-07-23 | TD Cowen | Maintains | Buy -> Buy |